ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessing Models of Exposure Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01679457
Recruitment Status : Active, not recruiting
First Posted : September 6, 2012
Last Update Posted : March 26, 2018
Sponsor:
Collaborator:
Utah State University
Information provided by (Responsible Party):
Nate Gruner, Mclean Hospital

Brief Summary:
The objective of this study is to learn how to improve treatment for clients who are working hard in treatment at the McLean Hospital Obsessive Compulsive Disorder Institute (OCDI), but who are not making the progress that would typically be expected. Therefore, the investigators will be comparing the performance of such clients in a treatment as usual (TAU)-Exposure and Response Prevention (ERP) session with their performance in an Acceptance and Commitment Therapy (ACT)-focused ERP session that follows an ACT booster session. The investigators hypothesize that clients will perform significantly better in the ACT-focused ERP session than they will in the TAU-ERP session. More specifically, the investigators hypothesize that clients and an independent rater will report that in the ACT-focused ERP session, clients performed significantly fewer rituals and/or avoidance behaviors, exerted significantly more effort, had significantly less difficulty getting started with the ERP, were significantly less influenced by their uncomfortable thoughts/feelings, were significantly more willing to experience discomfort, were significantly more focused on working towards what is important to the client. The investigators also hypothesize that an independent rater will rate clients as significantly more compliant with the ACT-focused ERP session than with the TAU-ERP session. The investigators also hypothesize that clients will rate the ACT-focused ERP session as significantly more preferable and acceptable than the TAU-ERP session, and that they will report being significantly more willing to do the ACT-focused ERP session again.

Condition or disease Intervention/treatment Phase
Obsessive-compulsive Disorders and Symptoms Behavioral: ACT-Focused ERP Behavioral: TAU-ERP Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Assessing Models of Exposure Therapy
Study Start Date : September 2012
Estimated Primary Completion Date : August 2018
Estimated Study Completion Date : August 2018

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: ACT-Focused ERP
One Session.
Behavioral: TAU-ERP
Active Comparator: TAU-ERP
One Session.
Behavioral: ACT-Focused ERP



Primary Outcome Measures :
  1. Client Post-ERP Session Questions (Day 1). [ Time Frame: Client Post-ERP Session Questions (Day 1) will be administered immediately after the "Day 1" TAU-ERP session. ]
  2. Client Post-ERP Session Questions (Day 2). [ Time Frame: Client Post-ERP Session Questions (Day 2) will be administered immediately after the "Day 2" ACT-focused ERP session. ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Participants will be adults at least 18 years of age currently enrolled in the residential or day treatment program at the OCDI.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01679457


Locations
United States, Massachusetts
Obsessive Compulsive Disorder Institute at McLean Hospital
Belmont, Massachusetts, United States, 02478
Sponsors and Collaborators
Mclean Hospital
Utah State University
Investigators
Principal Investigator: Nate G Gruner, LICSW Mclean Hospital

Responsible Party: Nate Gruner, Staff Behavior Therapist, Mclean Hospital
ClinicalTrials.gov Identifier: NCT01679457     History of Changes
Other Study ID Numbers: 2012-P-001010/1; McLean
First Posted: September 6, 2012    Key Record Dates
Last Update Posted: March 26, 2018
Last Verified: March 2018

Additional relevant MeSH terms:
Compulsive Personality Disorder
Obsessive-Compulsive Disorder
Personality Disorders
Mental Disorders
Anxiety Disorders